Who
Daniel Gordon Kirby
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, Iovance Biotherapeutics.
In numbers
- Trades disclosed
- 30
- Buys
- 1
- Sells
- 0
- Bought
- $55K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 10 Feb 2025
- Last trade
- 10 Aug 2026
- Last filed
- 12 Aug 2026
Companies traded
Activity over time
1 Jun 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Aug 2026filed 12 Aug 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —10,001 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $16K2,436 at $6.40 | filing |
| 10 Aug 2026filed 12 Aug 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,001 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,001 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —10,001 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $16K2,436 at $6.40 | filing |
| 11 May 2026filed 13 May 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 11 May 2026filed 13 May 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $9,0102,435 at $3.70 | filing |
| 11 May 2026filed 13 May 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 11 May 2026filed 13 May 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 11 May 2026filed 13 May 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 11 May 2026filed 13 May 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $9,0102,435 at $3.70 | filing |
| 9 Mar 2026filed 11 Mar 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —132,200 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —132,200 at $0.00 | filing |
| 24 Feb 2026filed 26 Feb 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —120,000 at $0.00 | filing |
| 24 Feb 2026filed 26 Feb 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $129K34,165 at $3.78 | filing |
| 24 Feb 2026filed 26 Feb 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —150,000 at $0.00 | filing |
| 24 Feb 2026filed 26 Feb 2026 | IOVA Iovance Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —150,000 at $0.00 | filing |
| 24 Feb 2026filed 26 Feb 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code M | —120,000 at $0.00 | filing |
| 24 Feb 2026filed 26 Feb 2026 | IOVA Iovance BiotherapeuticsBiotechnology | SEC FORM 4 Code F | $129K34,165 at $3.78 | filing |
News
Undercovered Stocks: Hess Midstream, Iovance Biotherapeutics, Netlist, And MoreIOVA · seekingalpha.com · 19 Oct 2026Comparing MannKind (NASDAQ:MNKD) & Iovance Biotherapeutics (NASDAQ:IOVA)IOVA · tickerreport.com · 15 Oct 2026Iovance Biotherapeutics (NASDAQ:IOVA) Price Target Raised to $11.00IOVA · themarketsdaily.com · 11 Oct 2026
0 headlines in the last 90 days name Daniel Gordon Kirby; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.